Literature DB >> 8780695

An Mse I RFLP in the human CTLA4 promotor.

K Deichmann1, A Heinzmann, E Brüggenolte, J Forster, J Kuehr.   

Abstract

We present a PCR-based Mse I restriction fragment length polymorphism (RFLP) in the promotor of the human CTLA4 gene at position -318 relative to the ATG start codon. In a random caucasian population including 239 individuals the allele frequency of the polymorphism was 13.4%, with a calculated heterozygosity rate of 23.2% and an observed one of 25.1%. CTLA4 and CD28 are two genes in close proximity on the long arm of chromosome 2. Both of them influence T-cell activity in an antigen-independent way. They represent candidate genes for several immunological disorders. Recently association between the CTLA4 gene and Graves' disease has been shown. The Mse I RFLP in the CTLA4 promotor might serve as a useful tool for further association studies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8780695     DOI: 10.1006/bbrc.1996.1256

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Evaluation of single nucleotide polymorphism typing with invader on PCR amplicons and its automation.

Authors:  C A Mein; B J Barratt; M G Dunn; T Siegmund; A N Smith; L Esposito; S Nutland; H E Stevens; A J Wilson; M S Phillips; N Jarvis; S Law; M de Arruda; J A Todd
Journal:  Genome Res       Date:  2000-03       Impact factor: 9.043

Review 2.  CTLA4 gene and autoimmune endocrinopathies: a new marker?

Authors:  F Pociot
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

3.  CTLA-4 gene polymorphism in promoter and exon-1 regions is not associated with Chinese patients with rheumatoid arthritis.

Authors:  Ming-Fei Liu; Chrong-Reen Wang; Pei-Chih Chen; Tsung-Liang Lin
Journal:  Clin Rheumatol       Date:  2004-01-28       Impact factor: 2.980

4.  Natural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's.

Authors:  Leila Ksiaa Cheikhrouhou; Yousr Lakhoua-Gorgi; Imen Sfar; Salwa Jendoubi-Ayed; Houda Aouadi; Mouna Makhlouf; Khaled Ayed; Taieb Ben Abdallah
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

5.  Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.

Authors:  Qin Zhang; Yun-mei Yang; Xue-ying Lv
Journal:  J Zhejiang Univ Sci B       Date:  2006-11       Impact factor: 3.066

6.  Association of polymorphic alleles of CTLA4 with inflammatory bowel disease in the Japanese.

Authors:  Haruhisa Machida; Kazuhiro Tsukamoto; Chun-Yang Wen; Yukiko Narumi; Saburou Shikuwa; Hajime Isomoto; Fuminao Takeshima; Yohei Mizuta; Norio Niikawa; Ikuo Murata; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

Review 7.  Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.

Authors:  Frank A Schildberg; Sarah R Klein; Gordon J Freeman; Arlene H Sharpe
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

8.  CTLA-4 +49A>G polymorphism is associated with the risk but not with the progression of colorectal cancer in Chinese.

Authors:  Peng Qi; Can-ping Ruan; Hao Wang; Fei-guo Zhou; Xin-yun Xu; Xing Gu; Yun-peng Zhao; Tong-hai Dou; Chun-fang Gao
Journal:  Int J Colorectal Dis       Date:  2009-09-29       Impact factor: 2.571

9.  Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population.

Authors:  Lie-Ying Fan; Xiao-Qing Tu; Qu-Bo Cheng; Ye Zhu; Ralph Feltens; Thomas Pfeiffer; Ren-Qian Zhong
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

10.  Association of cytotoxic T lymphocyte antigen-4 gene polymorphisms and HLA class II alleles with the development of type 1 diabetes in Korean children and adolescents.

Authors:  Min Ho Jung; Jeesuk Yu; Choong Ho Shin; Byung Kyu Suh; Sei Won Yang; Byung Churl Lee
Journal:  J Korean Med Sci       Date:  2009-11-07       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.